Pathobiology questions raised by telogen effluvium and trichodynia in COVID-19 patients.
作者信息
Di Landro Anna, Naldi Luigi, Glaser Ella, Paus Ralf, Tosti Antonella
机构信息
Centro Studi GISED, Bergamo, Italy.
Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
出版信息
Exp Dermatol. 2021 Jul;30(7):999-1000. doi: 10.1111/exd.14352. Epub 2021 May 4.
Abstract
摘要
相似文献
1
Pathobiology questions raised by telogen effluvium and trichodynia in COVID-19 patients.新冠病毒感染患者休止期脱发和毛发疼痛引发的病理生物学问题
Exp Dermatol. 2021 Jul;30(7):999-1000. doi: 10.1111/exd.14352. Epub 2021 May 4.
2
Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.新冠病毒感染患者的拔毛癖和休止期脱发：一项关于诊断和管理的国际专家意见调查结果
JAAD Int. 2021 Dec;5:11-18. doi: 10.1016/j.jdin.2021.07.006. Epub 2021 Aug 3.
3
COVID-19 infection is a major cause of acute telogen effluvium.COVID-19 感染是急性休止期脱发的主要原因。
Ir J Med Sci. 2022 Aug;191(4):1677-1681. doi: 10.1007/s11845-021-02754-5. Epub 2021 Aug 31.
4
The role of psychological factors and serum zinc, folate and vitamin B12 levels in the aetiology of trichodynia: a case-control study.心理因素及血清锌、叶酸和维生素 B12 水平在 trichodynia 发病机制中的作用：病例对照研究。
Clin Exp Dermatol. 2009 Oct;34(7):789-92. doi: 10.1111/j.1365-2230.2008.03165.x. Epub 2009 Apr 8.
5
Trichodynia is a distinguishing symptom of telogen effluvium.拔毛痛是休止期脱发的一个显著症状。
J Eur Acad Dermatol Venereol. 2009 Jun;23(6):733-4. doi: 10.1111/j.1468-3083.2009.03201.x. Epub 2009 Mar 5.
6
The presence of trichodynia in patients with telogen effluvium and androgenetic alopecia.休止期脱发和雄激素性脱发患者中毛痛的存在情况。
Int J Dermatol. 2003 Sep;42(9):691-3. doi: 10.1046/j.1365-4362.2003.01847.x.
7
What can the hair tell us about COVID-19?头发能告诉我们关于 COVID-19 的什么信息？
Exp Dermatol. 2021 Feb;30(2):288-290. doi: 10.1111/exd.14259. Epub 2020 Dec 28.
8
The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染及其疫苗在各类脱发中的作用
Dermatol Ther. 2022 Jun;35(6):e15433. doi: 10.1111/dth.15433. Epub 2022 Apr 1.
9
SARS-CoV-2-induced telogen effluvium: a multicentric study.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）诱发的休止期脱发：一项多中心研究。
J Eur Acad Dermatol Venereol. 2021 Mar;35(3):e181-e183. doi: 10.1111/jdv.17045. Epub 2020 Dec 9.
10
The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies.在长期新冠研究中并行分析休止期脱发和斑秃的必要性。
Influenza Other Respir Viruses. 2024 Jul;18(7):e13356. doi: 10.1111/irv.13356.
引用本文的文献
1
A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital.某三级护理医院关于冠状病毒病（COVID-19）后脱发的横断面研究
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023263. doi: 10.5826/dpc.1304a263.
2
[Review of the post-COVID-19 syndrome associated to acute telogen effluvium].[与急性休止期脱发相关的新冠后综合征综述]
Rev Med Inst Mex Seguro Soc. 2023 Jul 31;61(4):496-501. doi: 10.5281/zenodo.8200471.
3
Antinuclear Antibody Positivity in Patients With Hair Loss After COVID-19 Infection.新冠病毒感染后脱发患者的抗核抗体阳性
Dermatol Pract Concept. 2023 Apr 1;13(2). doi: 10.5826/dpc.1302a81.
4
The Effect of Covid-19 on the Hair Diseases Observed in Health Care Providers: Analysis of 513 Participants.新冠病毒对医护人员所患毛发疾病的影响：对513名参与者的分析。
Dermatol Pract Concept. 2023 Jan 1;13(1):e2023036. doi: 10.5826/dpc.1301a36.
5
Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.沙特阿拉伯公众接种新冠疫苗后出现的休止期脱发
J Family Med Prim Care. 2022 Oct;11(10):6056-6060. doi: 10.4103/jfmpc.jfmpc_377_22. Epub 2022 Oct 31.
6
Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.新冠病毒感染者休止期脱发的患病率及其与疾病严重程度的关系。
J Med Life. 2022 May;15(5):631-634. doi: 10.25122/jml-2021-0380.
7
Characteristics of hair loss after COVID-19: A systematic scoping review.新冠病毒感染后脱发的特征：系统综述性定题研究。
J Cosmet Dermatol. 2022 Sep;21(9):3655-3662. doi: 10.1111/jocd.15218. Epub 2022 Jul 19.
8
Alopecia in patients with COVID-19: A systematic review and meta-analysis.新型冠状病毒肺炎患者的脱发：一项系统评价与荟萃分析
JAAD Int. 2022 Jun;7:67-77. doi: 10.1016/j.jdin.2022.02.006. Epub 2022 Feb 22.
9
Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?大流行期间休止期脱发患者的评估：单核细胞是否是新冠后休止期脱发的原因？
J Cosmet Dermatol. 2022 May;21(5):1809-1815. doi: 10.1111/jocd.14883. Epub 2022 Feb 28.
10
COVID-19 induced telogen effluvium.COVID-19 引发的休止期脱发。
Dermatol Ther. 2021 Nov;34(6):e15175. doi: 10.1111/dth.15175. Epub 2021 Nov 6.
本文引用的文献
1
Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.新型冠状病毒肺炎相关过度炎症综合征的临床标准：一项队列研究
Lancet Rheumatol. 2020 Dec;2(12):e754-e763. doi: 10.1016/S2665-9913(20)30343-X. Epub 2020 Sep 29.
2
COVID-19-Related Anosmia: The Olfactory Pathway Hypothesis and Early Intervention.与新冠病毒相关的嗅觉丧失：嗅觉通路假说与早期干预
Front Neurol. 2020 Sep 10;11:956. doi: 10.3389/fneur.2020.00956. eCollection 2020.
3
Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.新冠病毒（SARS-CoV-2）与皮肤细胞受体的潜在相互作用：为了解与其他组织相比皮肤损伤频率较低的谜团。
Exp Dermatol. 2020 Oct;29(10):936-944. doi: 10.1111/exd.14186.
4
Olfactory receptor OR2AT4 regulates human hair growth.嗅觉受体 OR2AT4 调控人类头发生长。
Nat Commun. 2018 Sep 18;9(1):3624. doi: 10.1038/s41467-018-05973-0.
5
Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles.干扰素-γ是培养的人类生长期毛囊中退行期样变化的强效诱导剂。
Br J Dermatol. 2005 Apr;152(4):623-31. doi: 10.1111/j.1365-2133.2005.06453.x.
Zotero 插件